Identification of Replication-Competent Strains of Simian Immunodeficiency Virus Lacking Multiple Attachment Sites for N-Linked Carbohydrates in Variable Regions 1 and 2 of the Surface Envelope Protein

ABSTRACT Carbohydrates comprise about 50% of the mass of gp120, the external envelope glycoprotein of simian immunodeficiency virus (SIV) and human immunodeficiency virus. We identified 11 replication-competent derivatives of SIVmac239 lacking two, three, four, or five potential sites for N-linked glycosylation. These sites were located within and around variable regions 1 and 2 of the surface envelope protein of the virus. Asn (AAT) of the canonical N-linked glycosylation recognition sequence (Asn X Ser/Thr) was changed in each case to the structurally similar Gln (CAG or CAA) such that two nucleotide changes in the codon would be required for reversion. Replication of one triple mutant (g456), however, was severely impaired. A revertant of the g456 mutant was recovered from CEMx174 cells with a Met-to-Val compensatory substitution at position 144, 2 amino acids upstream of attachment site 5. Thus, a debilitating loss of sites for N-linked glycosylation can be compensated for by amino acid changes not involving the Asn-X-Ser/Thr consensus motif. These results provide a framework to begin testing the hypothesis that carbohydrates form a barrier that can limit the humoral immune responses to the virus.

[1]  J. Overbaugh,et al.  Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies , 1997, Journal of virology.

[2]  R. Desrosiers,et al.  A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation , 1997, Journal of virology.

[3]  John W. Mellors,et al.  Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences , 1997 .

[4]  R. Dwek,et al.  N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure , 1996, Journal of virology.

[5]  R. Dwek,et al.  N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120 , 1996, Journal of virology.

[6]  R. Desrosiers,et al.  Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements , 1996, Journal of virology.

[7]  M. Essex,et al.  Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert , 1996, Journal of virology.

[8]  R. Desrosiers,et al.  Improved recombinant PCR mutagenesis procedure that uses alkaline-denatured plasmid template. , 1995, BioTechniques.

[9]  J. Goudsmit,et al.  An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. , 1994, Virology.

[10]  R. Compans,et al.  Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides , 1994, Journal of virology.

[11]  P. Murphy,et al.  Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. , 1993, The Journal of biological chemistry.

[12]  R. Desrosiers,et al.  Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry. , 1993, Virology.

[13]  A. Heath,et al.  Sequence variation in the env gene of simian immunodeficiency virus recovered from immunized macaques is predominantly in the V1 region. , 1993, The Journal of general virology.

[14]  Lizhong,et al.  Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding , 1993, Journal of virology.

[15]  R. Desrosiers,et al.  Complex determinants of macrophage tropism in env of simian immunodeficiency virus , 1992, Journal of virology.

[16]  B. Du,et al.  Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Hatzfeld,et al.  DNA transfection in COS cells: a low-cost serum-free method compared to lipofection. , 1991, BioTechniques.

[18]  J. Ledbetter,et al.  Effects of mutations in glycosylation sites and disulphide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteins. , 1991, The Journal of general virology.

[19]  R. Desrosiers,et al.  Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys , 1991, Journal of virology.

[20]  J. Moore,et al.  Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2. , 1991, Virology.

[21]  R. Desrosiers,et al.  The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. , 1990, AIDS research and human retroviruses.

[22]  Reed J. Harris,et al.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.

[23]  E. Fenouillet,et al.  Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1 , 1990, Journal of virology.

[24]  R. Lamb,et al.  Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase , 1990, Molecular and cellular biology.

[25]  R. Pal,et al.  Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Lasky,et al.  Model for intracellular folding of the human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.

[27]  P. Sehgal,et al.  Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac , 1988, Journal of virology.

[28]  A. Pinter,et al.  O-linked glycosylation of retroviral envelope gene products , 1988, Journal of virology.

[29]  P. Earl,et al.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.

[30]  H. Ploegh,et al.  Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase , 1987, Nature.

[31]  B. Walker,et al.  Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.